版塊導(dǎo)航: 正在加載中...

登錄注冊

應(yīng)《網(wǎng)絡(luò)安全法》要求，自2017年10月1日起，未進行實名認證將不得使用互聯(lián)網(wǎng)跟帖服務(wù)。為保障您的帳號能夠正常使用，請盡快對帳號進行手機號驗證，感謝您的理解與支持！

24小時熱門版塊排行榜

返回列表

本帖產(chǎn)生 1 個翻譯EPI ，點擊這里進行查看

liyan20220

木蟲 (著名寫手)

應(yīng)助: 4 (幼兒園)
金幣: 7624.7
散金: 1615
紅花: 33
帖子: 2264
在線: 698.2小時
蟲號: 689990
注冊: 2009-01-08
專業(yè): 生物大分子結(jié)構(gòu)與功能

[求助] 求翻譯一段為英文

結(jié)核病是由人類重大病原菌結(jié)核桿菌引發(fā)的呼吸道傳染病，隨著多種有效控制結(jié)核病的抗生素的大量應(yīng)用，多重耐藥結(jié)核桿菌菌株大量出現(xiàn)，而傳統(tǒng)抗生素?zé)o法達到治療效果，因此，開發(fā)新型抗結(jié)核桿菌藥物迫在眉睫。噬菌體作為一種真細菌的病毒，可以有效地與宿主細菌作用，作為替代傳統(tǒng)抗生素的藥物受到廣泛的關(guān)注。多肽PK34來源于結(jié)核分枝桿菌噬菌體，具有清除體內(nèi)結(jié)核分枝桿菌的能力，但是，目前其抗結(jié)核分枝桿菌的作用機制研究還未有報道，本項目擬利用基因工程法獲得抗結(jié)核分枝桿菌多肽PK34，并利用核磁共振為主要研究手段，結(jié)合圓二色譜等其他手段，研究抗結(jié)核分枝桿菌多肽PK34與TDM相互作用的動態(tài)過程及其在TDM存在情況下的溶液結(jié)構(gòu)，并探索抗結(jié)核分枝桿菌多肽PK34的抗結(jié)核分枝桿菌作用機理，為闡明其抗結(jié)核分枝桿菌的作用機理提供重要的理論依據(jù)。

回復(fù)此樓

» 猜你喜歡

323求調(diào)劑已經(jīng)有6人回復(fù)
一志愿北京化工大學(xué) 070300 學(xué)碩 336分求調(diào)劑已經(jīng)有4人回復(fù)
352求調(diào)劑已經(jīng)有3人回復(fù)
一志愿東華大學(xué)化學(xué)070300，求調(diào)劑已經(jīng)有8人回復(fù)
277材料科學(xué)與工程080500求調(diào)劑已經(jīng)有7人回復(fù)
317求調(diào)劑已經(jīng)有18人回復(fù)
293求調(diào)劑已經(jīng)有5人回復(fù)
280分求調(diào)劑一志愿085802 已經(jīng)有7人回復(fù)
0854電子信息求調(diào)劑已經(jīng)有3人回復(fù)
263求調(diào)劑已經(jīng)有4人回復(fù)

1樓 2014-09-12 07:18:07

已閱回復(fù)此樓關(guān)注TA 給TA發(fā)消息送TA紅花 TA的回帖

ssssllllnnnn

至尊木蟲 (知名作家)

Translator and Proofreader

翻譯EPI: 1690
應(yīng)助: 452 (碩士)
金幣: 31580.9
紅花: 100
帖子: 7681
在線: 19966.6小時
蟲號: 3328089
注冊: 2014-07-17
專業(yè): 腫瘤發(fā)生

【答案】應(yīng)助回帖

★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
liyan20220: 金幣+25, 翻譯EPI+1, ★★★★★最佳答案 2014-09-12 09:19:04

你的中文摘要最后兩句話“并探索抗結(jié)核分枝桿菌多肽PK34的抗結(jié)核分枝桿菌作用機理，為闡明其抗結(jié)核分枝桿菌的作用機理提供重要的理論依據(jù)”是重復(fù)的（說了同一件事）。我在翻譯時將最后一句變成了為其抗結(jié)核治療作用提供重要理論基礎(chǔ)，不知是否合適。

Tuberculosis (TB) is a respiratory infectious disease caused by Mycobacterium tuberculosis, a major pathogenic bacterial species in the family Mycobacteriaceae. With the large-scale application of a variety of effective antibiotics (to control TB), multidrug-resistant Mycobacterium tuberculosis strains emerged, which cannot be treated effectively with the traditional antibiotics. Therefore, it is the imminent to develop new anti-TB drugs. As a virus of eubacteria, a bacteriophage can infect and replicate within Mycobacterium tuberculosis. Recently, much attention has been paid to bacteriophage as an alternative to traditional antibiotic drugs. Polypeptide PK34, derived from Mycobacterium tuberculosis phage, is capable of getting rid of Mycobacterium tuberculosis from body. However, the underlying mechanisms of its anti-Mycobacterium tuberculosis effect has not been reported.
In this project, polypeptide PK34 of Mycobacterium tuberculosis will be obtained by utilizing of genetic engineering methods and the dynamic interaction between PK34 and TDM, as well as the solution structure of PK34 in the presence of TDM will be investigated with MRI as the main research tool, in combination with other methods, such as circular dichroism. The mechanisms of the anti-Mycobacterium tuberculosis effect of polypeptide PK34 will be explored in order to provide important theoretical basis for its therapeutic action.

贊一下

回復(fù)此樓

2樓2014-09-12 07:42:29